Cargando…
Timing of corticosteroids in non-severe non-hospitalized COVID-19 patients: open-label, two-center, randomized controlled study (TICS-COV19 study)
BACKGROUND/AIMS: Corticosteroids (CSs) are frequently used in coronavirus disease 2019 (COVID-19); however, their utility remains controversial in mild to moderate cases. The timing of CSs initiation during the disease course remains unaddressed. The study aims to evaluate the impact of early CSs in...
Autores principales: | Issak, Emad R., Amin, Mariam M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association of Internal Medicine
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993104/ https://www.ncbi.nlm.nih.gov/pubmed/36646988 http://dx.doi.org/10.3904/kjim.2022.232 |
Ejemplares similares
-
Corticosteroids for Non-severe COVID-19: Primum Non Nocere
por: Muthu, Valliappan, et al.
Publicado: (2022) -
Open-label study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders
por: Yoo, Hanik K., et al.
Publicado: (2010) -
Expert Consensus Statements on the Use of Corticosteroids in Non-severe COVID-19
por: Nasa, Prashant, et al.
Publicado: (2021) -
In Response to: Corticosteroids in Non-severe COVID-19: Finding Window of Opportunity
por: Nasa, Prashant, et al.
Publicado: (2022) -
Corticosteroids for non-severe COVID-19 infections? Too early to conclude
por: Park, Sunghoon
Publicado: (2023)